β-hydroxybutyrate inhibits malignant phenotypes of prostate cancer cells through β-hydroxybutyrylation of indoleacetamide-N-methyltransferase
Article in Cancer Cell International (March 2024)
The most recent citing publications are shown below. View all 9 publications that cite this research output on Dimensions.
Article in Cancer Cell International (March 2024)
Article in Frontiers in Pharmacology (February 2024)
Article in Genomics (January 2024)